PML with dimethyl fumarate-No role for natalizumab?

Mult Scler. 2019 Oct;25(12):1686-1687. doi: 10.1177/1352458519872897. Epub 2019 Aug 22.

Author

Joseph R Berger¹

Affiliation

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

PMID: 31436127
DOI: 10.1177/1352458519872897

No abstract available

Publication types

Comment

MeSH terms

Dimethyl Fumarate
Humans
Immunosenescence*
Leukoencephalopathy, Progressive Multifocal*
Lymphopenia*
Multiple Sclerosis*
Natalizumab

Substances

Natalizumab
Dimethyl Fumarate